Biotech companies have lost the focus of investors, as all aspects of digitization currently dominate equity portfolios. And this despite high volatility as on Facebook1 and Twitter2 stocks. Nevertheless, the growing biotech industry is constantly appearing in the media with their future trends, such as cancer treatment, prolonging life or important vaccines. Biotech companies use almost all their resources for selective research and development. This contrasts sharply with companies in the digital economy, where rapid global scaling and market leadership are achieved with enormous capital spending.

Comparison MVIS US Listed Biotech 25 and S&P 500 over 3 months trailing (in USD)